This is the authors' abstract. We don't add key points for this paper.
Candida species are ubiquitous fungal pathogens that exhibit increasing resistance to anti-fungal agents. Candida haemulonii , a rare subtype, is an emerging and virulent yeast pathogen. Species identification is difficult due to phenotypic similarity to other Candida subtypes, such that there is a high risk of inappropriate antimicrobial administration and worsening of emerging resistance patterns. Candida haemulonii has a proclivity for infection of chronic lower extremity wounds particularly in diabetic patients, as exemplified in our case. This case raises awareness about the necessity for expeditious identification and antimicrobial stewardship directed to a highly resistant emerging pathogen.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Coles et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: